Quillen,K.

官方网页 科教人文：Quillen,K.

官方网页科教人文Quillen,K.个人资料、作品Quillen，K.个人资料，教授-波士顿大学-个人资料，近期论文 Bauza G， Hirsch E， Burke P， Quillen K. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy. Transfusion 2007; 47:749-751. Quillen K， Hu E， Lane C， Pelton S， Bateman S. Prevalence of ceftriaxone-

Quillen,K.的相关资料

近期论文Bauza G, Hirsch E, Burke P, Quillen K. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy. Transfusion 2007; 47:749-751.Quillen K, Hu E, Lane C, Pelton S, Bateman S. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric HIV and sickle cell patients. Pediatr Infect Dis J 2008; 27: 357-8.Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka H, Scheinberg P, Pantin J, Quillen K. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009; 49: 1845-1849.Wang D, Lane C, Quillen K. Prevalence of RhD variants, confirmed by molecular genotyping, in a multi-ethnic prenatal population. Am J Clin Pathol 2010; 134: 438-442.Quillen K, Sheldon SL, Daniel-Johnson JA, Lee-Stroka AH, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. Transfusion 2011; 51: 92-96.Quillen K, Medrano C, Adams S, Peterson B, Hackett JA, Leitman SF, Klein HG, Stroncek DF. Screening plateletpheresis donors for HLA antibodies on two high throughput platforms and correlation with recipient outcome. Transfusion 2011; 51: 504-510.Quillen K, Seldin DC, Finn KT, Sanchorawala V. A second course of high-dose melphalan and autologous stem cell transplantation for the treatment of relapsed AL amyloidosis. Bone Marrow Transplant 2010 Oct 18 [

Quillen,K.的直播间（主页）

Quillen,K.的相关搜索

Quillen,近期,论文,Bauza,Hirsch,Burke,Quillen,Low-dose,。

达人导航小编发现Quillen,K.在官方网页 非常受大家欢迎，请扫码打开Quillen,K.的主页进行了解。